Skip to content

Clinical trials

Phase 1 Post-Acute COVID-19 Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 1 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20223
20235
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed4
Recruiting3
Terminated2
Suspended1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hackensack Meridian Health2
American CryoStem Corporation1
Charles Cox1
Huazhong University of Science and Technology1
Johns Hopkins University1
Jonathann Kuo, MD1
National Institute of Mental Health (NIMH)1
National Institute of Neurological Disorders and Stroke (NINDS)1
Neobiosis, LLC1
State University of New York at Buffalo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome16
COVID-197
Cognitive Dysfunction2
Autonomic Nervous System Diseases1
Chronic Cough1
Dyspnea1
Inflammation1
Multiple Sclerosis1
Nerve Degeneration1
Neurologic Manifestations1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.